NCT04964258View on ClinicalTrials.gov

A Study of TAK-105 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

July 26, 2021

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-105-a

TAK-105-a subcutaneous solution.

DRUG

TAK-105-a Placebo

TAK-105-a placebo-matching solution.

Trial Locations (3)

78744

PPD Development, LP, Austin

85283

Celerion, Tempe

89113

PPD Development, LP, Las Vegas

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY